Omeros | Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Adma Biologics USD 47.52M 7.42M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cytokinetics USD -306.18M 171.81M 2025-09
Dynavax Technologies USD 28.42M 7.2M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Immunic USD -21.38M 8.2M 2024-06
Insmed USD -368.7M 48.26M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD -1.93M 10.63M 2025-06
Pfizer USD 3.33B 290M 2025-09
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
United Therapeutics USD 438M 29.6M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06


Omeros Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.